Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosocomial bacterial infections in recent years. It was one of the major causes of secondary infections in Covid-19 patients in developing countries. The polycationic polypeptide antibiotic colistin is used as a last resort drug to treat carbapenem resistant A. baumannii infections. Therefore, resistance to colistin is considered as a serious medical threat. The purpose of this study was to assess the current status of colistin resistance in Pakistan, a country where carbapenem resistant A. bumannii infections are endemic, to understand the impact of colistin resistance on virulence in mice and to assess alternative strategies to treat such infect...
Overcoming colistin-resistant Acinetobacter baumannii (CoR-AB) has become a major concern due to the...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Published Online: 01/01/2014The emergence of pan-resistance in bacterial pathogens poses a threat to...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
[[abstract]]Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen....
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
International audienceDespite having a reputation of low virulence, Acinetobacter baumannii is an em...
Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-negative b...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
textMultidrug-resistant (MDR) Acinetobacter baumannii have caused nosocomial infections worldwide. N...
Copyright © 2009 The British Infection Society Published by Elsevier Ltd.Background Multidrug-resist...
Colistin is drug of choice for treatment of carbapenem-resistant Acinetobacter baumannii infections....
Overcoming colistin-resistant Acinetobacter baumannii (CoR-AB) has become a major concern due to the...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Published Online: 01/01/2014The emergence of pan-resistance in bacterial pathogens poses a threat to...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Carbapenem resistant Acinetobacter baumannii has emerged as one of the most difficult to treat nosoc...
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-c...
Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen. Colistin-re...
[[abstract]]Acinetobacter baumannii, a Gram-negative bacterium, is an important nosocomial pathogen....
Acinetobacter baumannii is a significant cause of opportunistic hospital acquired infection and has ...
International audienceDespite having a reputation of low virulence, Acinetobacter baumannii is an em...
Colistin is one of the last remaining active antibiotics against multidrug resistant Gram-negative b...
Emergence of resistant strain to antimicrobials is a growing problem worldwide. Here, we report a ca...
textMultidrug-resistant (MDR) Acinetobacter baumannii have caused nosocomial infections worldwide. N...
Copyright © 2009 The British Infection Society Published by Elsevier Ltd.Background Multidrug-resist...
Colistin is drug of choice for treatment of carbapenem-resistant Acinetobacter baumannii infections....
Overcoming colistin-resistant Acinetobacter baumannii (CoR-AB) has become a major concern due to the...
Background: As carbapenem-resistant Acinetobacter baumannii is dominant in clinical settings, the ol...
Published Online: 01/01/2014The emergence of pan-resistance in bacterial pathogens poses a threat to...